Rubella seroprevalence in an unvaccinated population in Izmir: Recommendations for rubella vaccination in Turkey

Pediatric Infectious Disease Journal

Volumn 18, Issue 7, 1999, Pages 577-580

  Aksit, Sadik ^a,b   Egemen, Ayten ^a   Ozacar, Tijen ^a   Kurugol, Zafer ^a   Keskinoglu, Pembe ^b   Tasbakan, Meltem ^a   Caglayan, Suat ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Mimkent 2 Konutlari ^*

Author keywords

Congenital rubella syndrome; Rubella; Seroprevalence; Vaccination

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; RUBELLA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONGENITAL RUBELLA SYNDROME; DEMOGRAPHY; DISEASE PREDISPOSITION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RUBELLA; SERODIAGNOSIS; SEROPREVALENCE; TURKEY (REPUBLIC); VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; INFANT; MALE; RUBELLA; RUBELLA SYNDROME, CONGENITAL; RUBELLA VACCINE; RUBELLA VIRUS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; TURKEY; VACCINATION;

EID: 0032797013     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199907000-00003     Document Type: Article

References (24)

1. Gregg NM. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 1941;3:35-46.
2. Peckham CS. Clinical and laboratory study of children exposed in utero to maternal rubella. Arch Dis Child 1972;47: 571-7.
3. Centers for Disease Control and Prevention. Summary for notifiable diseases: United States. MMWR 1992;1992;41:3.
4. Centers for Disease Control and Prevention. Measles, mumps, and rubella: vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998;47:5.
5. Centers for Disease Control and Prevention. Rubella and congenital rubella syndrome: United States, 1994-1997. MMWR 1997;46:350.
6. Centers for Disease Control and Prevention. Rubella and congenital rubella syndrome: United States, January 1, 1991-May 7, 1994. MMWR 1994;43:397.
7. Peltola H, Heinonen OP, Valle M, et al. The elimination of indigeneous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 1994; 331:1397-402.
8. European Advisory Group on the Expanded Programme on Immunization (EAG/EPI). Report on the Fourteenth meeting, London, United Kingdom, January 27 to 29, 1998.
9. Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 2: vaccination against rubella. Bull World Health Organ 1997;75:69-80.
10. Henderson RH, Sundaresan T. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull World Health Organ 1982;60: 253-60.
11. Massad E, Burattini MN, de Azevado Neto RS, Yang HM, Coutinho FH, Zanetta DM. A model-based design of a vaccination strategy against rubella in a non-immunized community of Sao Paulo State, Brazil. Epidemiol Infect 1994;112: 579-94.
12. De Azevado Neto RS, Silveira AS, Nokes DJ, et al. Rubella seroepidemiology in a non-immunized population of Sao Paulo State, Brazil. Epidemiol Infect 1994;113:161-73.
13. Jose MV, Olvera J, Serrano O. Epidemiology of rubella in Mexico. Salud Publica Mex 1992;34:318-27.
14. Anderson RM, May RM. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond) 1983;90:259-325.
15. Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 2: vaccination against rubella. Bull World Health Organ 1997;75:69-80.
16. Gomwalk NE, Ezeronye OU. Sero-epidemiology of rubella in Imo State of Nigeria. Trans R Soc Trop Med Hyg 1985;79: 777-80.
17. Satpathy G. Seroepidemiology of rubella in Indian women and in children with congenital malformations. Virus Information Exchange Newslett 1989;6:126.
18. Strauss J, Dobahi SS, Danes L, Kopecky K, Svandova E. Serological survey of rubella in Yemen. J Hyg Epidemiol Microbiol Immunol 1989;33:163-7.
19. Dilmen U, Kaya S, Ciftci U, Göksin E. Rubella and toxoplasmosis in gestation, stillborn babies and in aborts. Doga Tr Med Sci 1990;14:294.
20. Guner H, Gunay A, Rota S. Seroprevalence of rubella virus in Turkish pregnant women. Int J Gynecol Obstet 1994;44:139-41.
21. The Ministry of Health of Turkey. Country Health Report 1997. Ankara, 1997:21-6.
22. Plotkin SA. Rubella vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines. 2nd ed. London: Saunders, 1994:123-35.
23. Cochi SL, Edmonds LE, Dyer K, et al. Congenital rubella syndrome in the United States, 1970-1985: on the verge of elimination. Am J Epidemiol 1989;129:349-61.
24. Lindegren ML, Fehrs LJ, Hadler SC, Hinman AR. Update: rubella and congenital rubella syndrome, 1980-1990. Epidemiol Rev 1991;13:341-8.